Evidence map›Paper›PMID 31397494›Full record

ArticleJournal of cellular physiology2020

CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.

Sara Bruschini, Simona di Martino, Maria Elena Pisanu, Luigi Fattore, Claudia De Vitis, Valentina Laquintana, Simonetta Buglioni, Eugenio Tabbì, Andrea Cerri, Paolo Visca and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. [Targeted killing of CD133Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 2 countries.

Sara BruschiniDepartment of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Simona di MartinoPhatology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Maria Elena PisanuHigh Resolution NMR Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
Luigi FattoreDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
Claudia De VitisDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Valentina LaquintanaPhatology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Simonetta BuglioniPhatology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Eugenio TabbìDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Andrea CerriPreclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Paolo ViscaPhatology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Gabriele AlessandriniThoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Francesco FaccioloThoracic Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Christian NapoliDepartment of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Marcella TrombettaTissue Engineering and Chemistry for Engineering Lab, Department of Engineering, University Campus Bio-Medico, Rome, Italy.
Antonio SantoroUCS Diagnostic S.r.l., Rome, Italy.
Anna CrescenziSection of Pathology, University Hospital Campus Bio-Medico of Rome, Rome, Italy.
Gennaro CilibertoScientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Rita ManciniDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-5491-2449
National Cancer Institute · MYSapienza University of Rome · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversità Campus Bio-Medico · ITConsorzio Interuniversitario Nazionale per l'Informatica · ITIstituto Pasteur · ITIstituto Superiore di Sanità · ITMagna Graecia University · ITServizio Sanitario Nazionale · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs) are a subpopulation with the properties of extensive self-renewal, capability to generate differentiated cancer cells and resistance to therapies. We have previously shown that malignant pleural effusions (MPEs) from patients with non-small-cell lung cancer (NSCLC) represent a valuable source of cancer cells that can be grown as three-dimensional (3D) spheroids enriched for stem-like features, which depend on the activation of the Yes-associated protein-transcriptional coactivator with PDZ-binding motif (YAP-TAZ)/Wnt-βcatenin/stearoyl-CoA desaturase 1 (SCD1) axis. Here, we describe a novel support, called CytoMatrix, for the characterization of limited amounts of cancer cells isolated from MPEs of patients with NSCLC. Our results show that this synthetic matrix allows an easy and fast characterization of several epithelial cellular markers. The use of CytoMatrix to study CSCs subpopulation confirms that SCD1 protein expression is enhanced in 3D spheroids when compared with 2D adherent cell cultures. YAP/TAZ nuclear-cytoplasmic distribution analysed by CytoMatrix in 3D spheroids is highly heterogeneous and faithfully reproduces what is observed in tumour biopsies. Our results confirm and extend the robustness of our workflow for the isolation and phenotypic characterization of primary cancer cells derived from the lung MPEs and underscore the role of SCD1.

Indexed as

AgedBiomarkers, TumorCarcinoma, Non-Small-Cell LungCell Culture TechniquesCell NucleusCytodiagnosisCytoplasmFemaleHumansLungLung NeoplasmsMaleMiddle AgedNeoplastic Stem CellsPleural Effusion, MalignantSpheroids, CellularBiomarkers, TumorStearoyl-CoA DesaturaseTranscription Factorscancer stem cellsCytoMatrixlung cancerMPEsSCD1

Identifiers

PMID31397494
PMCPMC6916247
OpenAlexW2969029176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.